U.S. Online Retail and Ecommerce Stock News

Major stock indexes in the United States recently ended lower as investors weighed earnings reports and ongoing U.S.-China trade tensions. In such a fluctuating market, penny stocks—despite their somewhat outdated moniker—remain a compelling area for investment, particularly when they are backed by solid financials. These smaller or newer companies can offer surprising value and potential for growth, making them worth considering for investors seeking hidden opportunities in quality stocks.

In October 2025, the U.S. stock market has been navigating a complex landscape marked by renewed U.S.-China trade tensions and mixed earnings reports, leading to declines in major indices such as the Nasdaq, Dow Jones Industrial Average, and S&P 500. Amidst this backdrop of uncertainty and fluctuating investor sentiment, identifying promising small-cap stocks can offer unique opportunities for those looking to uncover potential growth avenues in less-explored corners of the market.

As the U.S. stock market grapples with earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have ended lower. In such uncertain times, dividend stocks can offer a reliable income stream for investors seeking stability amidst market volatility.

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Earlier this week, Verastem Oncology announced promising preliminary data from the Phase 1/2a clinical trial of VS-7375, an oral KRAS G12D inhibitor, in patients with advanced KRAS G12D mutant solid tumors, along with the initiation of a combination cohort with cetuximab. These findings are significant, as there are currently no FDA-approved therapies specifically targeting KRAS G12D mutations in cancer, addressing a critical gap for patients with limited treatment options. We'll explore how...

Altisource Portfolio Solutions (ASPS) remains unprofitable but has managed to reduce its annual losses by 33.9% per year over the past five years. While the company’s net income has not turned positive and profit growth has not accelerated recently, its Price-To-Sales Ratio of 0.8x stands well below the peer average of 3.4x and the US Real Estate sector average of 2.6x. Investor attention is likely to center on operational progress and revenue momentum, even as shareholder dilution and...

Annaly Capital Management (NLY) just posted forecasts pointing to annual earnings growth of 28.07% and revenue set to climb by 21.8% each year, both comfortably ahead of US market averages. The company became profitable over the past year, with net profit margins improving during the period. For investors, strong growth prospects and a track record of high-quality earnings are balanced by some caution around financial stability and dividend sustainability. See our full analysis for Annaly...

MRC Global (MRC) has recently drawn attention as investors look for value plays in the industrial sector. The stock’s performance over the past year has shown a positive trend, and participants are closely watching for shifts in market sentiment. See our latest analysis for MRC Global. The momentum around MRC Global is building as the stock’s share price has climbed steadily so far in 2024, with a notable 10.3% year-to-date share price return. Over the past year, total shareholder return sits...

Solana (HSDT) triggered fresh attention this week by making its resale registration effective. This move unlocked previously restricted shares for early investors after a sizable private placement. The result was an immediate spike in trading activity and pronounced price movement. See our latest analysis for Solana. While broader markets have been steady, Solana’s shares took a dramatic turn after unlocking private investor shares, triggering a 60% drop in the past week alone. That sharp...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kanzhun fair value estimate is US$26.89 Current share price of...

As the U.S. stock market experiences gains amid trade news with China and a surge in oil futures, investors are keeping a close eye on emerging opportunities. Penny stocks, despite their somewhat outdated label, remain an intriguing area for those interested in smaller or newer companies that might offer untapped potential. These stocks can provide growth opportunities at lower price points when supported by strong financials and sound fundamentals.

Insiders who purchased Tharimmune, Inc. ( NASDAQ:THAR ) shares in the past 12 months are unlikely to be deeply impacted...

It's been a soft week for Nephros, Inc. ( NASDAQ:NEPH ) shares, which are down 13%. But over the last three years the...

Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...

Spectral AI, Inc. ( NASDAQ:MDAI ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights Significant control over Forge Global Holdings by retail investors implies that the general public has...

Key Insights Given the large stake in the stock by institutions, SkyWater Technology's stock price might be vulnerable...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...

Rambus Inc. ( NASDAQ:RMBS ) shareholders have seen the share price descend 12% over the month. But that doesn't...

Armata Pharmaceuticals (ARMP) just reported encouraging Phase 2a trial results for its experimental IV bacteriophage therapy, AP-SA02, targeting complicated Staphylococcus aureus bacteremia. The data was revealed during a presentation at IDWeek 2025. See our latest analysis for Armata Pharmaceuticals. News of Armata’s clinical breakthrough sent its share price surging 103% in a single day, fueling a remarkable 261% gain for investors year-to-date. Recent momentum has reversed previous years...

Amidst a backdrop of U.S.-China trade tensions and ongoing government shutdown, major stock indexes have ended lower as investors digest recent earnings reports. In this challenging market environment, identifying promising small-cap stocks can be pivotal, especially those that show resilience and potential for growth despite broader economic pressures.

As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have recently faced downward pressure. In such a volatile environment, identifying high growth tech stocks requires careful consideration of their resilience to geopolitical issues and their ability to innovate amidst economic challenges.